Loading…
Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer
Objective The objective of this paper is to conduct a prospective, longitudinal study employing the Memorial Anxiety Scale for Prostate Cancer (MAX‐PC) to examine the baseline and follow‐up association of prostate cancer (PCa)‐specific anxiety, health‐related quality of life (HRQOL), and PCa aggress...
Saved in:
Published in: | Psycho-oncology (Chichester, England) England), 2015-04, Vol.24 (4), p.451-457 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
The objective of this paper is to conduct a prospective, longitudinal study employing the Memorial Anxiety Scale for Prostate Cancer (MAX‐PC) to examine the baseline and follow‐up association of prostate cancer (PCa)‐specific anxiety, health‐related quality of life (HRQOL), and PCa aggressiveness in men with newly‐diagnosed PCa undergoing prostatectomy at our institution.
Methods
From our prospective PCa registry, we identified a total of 350 men with newly‐diagnosed PCa who completed the MAX‐PC and the Expanded Prostate Cancer Index Composite (EPIC) at baseline and one‐year following surgery. Scores on both measures were compared with clinical measure and demographics using the Wilcoxon Rank Sum, Fisher's exact, and Cochran‐Armitage Trend tests. Spearman test was used to assess correlation at between the MAX‐PC and EPIC at baseline and one‐year.
Results
Baseline overall MAX‐PC measures were correlated with measures at one‐year (r = 0.5479, p 6 (p = 0.004), T‐Stage ≥ 2C disease (p = 0.004), and a postoperative prostate‐specific antigen (PSA) > 0.1 (p = 0.002); however, this did not apply to all anxious patients. Baseline EPIC sexual function scores were predictive of follow‐up EPIC sexual function scores as well (r = 0.5790, p |
---|---|
ISSN: | 1057-9249 1099-1611 |
DOI: | 10.1002/pon.3605 |